Skip to main content
Indivior PLC logo

Indivior PLC — Investor Relations & Filings

Ticker · INDV ISIN · GB00BN4HT335 LEI · 213800V3NCQTY7IED471 IL Manufacturing
Open in API
Filings indexed 1,983 across all filing types
Latest filing 2024-12-31 Regulatory Filings
Country GB United Kingdom
Listing IL INDV

About Indivior PLC

https://www.indivior.com/en

Indivior PLC is a global pharmaceutical company that develops, manufactures, and sells medicines to treat substance use disorders (SUD) and serious mental illnesses. The company's primary focus is on pioneering treatments for opioid use disorder (OUD), with a portfolio centered on buprenorphine-based prescription pharmaceuticals. Through its research and development efforts, Indivior aims to address the complex challenges of addiction and behavioral health by providing innovative, life-transforming therapies for patients worldwide.

Recent filings

Filing Released Lang Actions
HOLDING(S) IN COMPANY
Regulatory Filings
2024-12-31 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-12-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document is explicitly labeled with "RNS Number : 7600R" and contains standard regulatory disclosure tables, specifically 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in major shareholdings, which falls under the category of significant ownership changes. The closest matching category is 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2024-12-31 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is a 'WEEKLY REPORT' concerning the 'SHARE REPURCHASE PROGRAM' of Indivior PLC. It details the number of shares purchased for cancellation during a specific period (December 23, 2024, up to and including December 27, 2024) and provides aggregated transaction data. This activity directly corresponds to the definition of a company buying back or selling its own shares, which maps precisely to the 'Transaction in Own Shares' category (POS). The RNS Number format also suggests a regulatory disclosure, but the content is highly specific to share repurchases.
2024-12-31 English
TRANSACTION IN OWN SHARES
Regulatory Filings
2024-12-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states it is a 'SHARE REPURCHASE PROGRAM WEEKLY REPORT' from Indivior PLC. It details the number of ordinary shares purchased for cancellation during a specific period (December 16, 2024, up to and including December 20, 2024) as part of a Share Repurchase Program. This directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase activities. The RNS Number format and the mention of RNS as the information provider confirm it is a regulatory announcement, but the content is specifically about share transactions, making POS the most precise classification over the general RNS fallback.
2024-12-24 English

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.